Home » BIOXEL LOOKS TO CONTRACTORS FOR SCALE-UP

BIOXEL LOOKS TO CONTRACTORS FOR SCALE-UP

June 6, 2006

Bioxel, a company which manufactures and markets taxane active pharmaceutical ingredients (APIs) used in chemotherapeutic drugs, has turned to two contract manufacturing companies to scale up production.

In-PharmaTechnologist.com (http://www.in-pharmatechnologist.com/news/ng.asp?n=68190-bioxel-taxanes-paclitaxel-docetaxel)

KEYWORDS Daily International Pharma Alert

08Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11Oct
1st Annual Quality Management vSummit

BIOXEL LOOKS TO CONTRACTORS FOR SCALE-UP

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

1st Annual Quality Management vSummit

Featured Products

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

Hyris T-Cell Test Gains CE-IVD Mark

FDA Expands Approval of Bayer’s Nubeqa for Prostate Cancer

MicroPort Navibot Receives 510(k) Clearance for Its SkyWalker System

The Revised ICH E8: A Guide to New Clinical Trial Requirements